🇺🇸 FDA
Patent

US 11286291

Co-stimulatory domains for use in genetically-modified cells

granted A61KA61K2039/505A61K2239/38

Quick answer

US patent 11286291 (Co-stimulatory domains for use in genetically-modified cells) held by Precision BioSciences, Inc. expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision BioSciences, Inc.
Grant date
Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K2239/38, A61K2239/48, A61K38/00